RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Small cell lung cancer (SCLC) is a highly aggressive malignancy with poor prognosis.
• Genetic alterations, particularly in RNA binding proteins, are implicated in SCLC development.
• RBM5 is a known tumor suppressor in SCLC, and its expression is often decreased.

Purpose of the Study:

• To investigate the role of RNA binding protein RBM10 in SCLC, hypothesizing it shares tumor-suppressor properties with RBM5.
• To elucidate the regulatory relationship between RBM5 and RBM10 in SCLC.

Main Methods:

• Transcriptome analysis and functional assays were performed on SCLC cell lines.
• RNA immunoprecipitation followed by next-generation sequencing (RIP-Seq) was used.
• Western blotting was employed to assess protein expression and interactions.

Main Results:

• Contrary to the hypothesis, RBM10 promoted cell proliferation and transformation-associated processes in RBM5-null SCLC cells.
• RBM5 was found to post-transcriptionally regulate RBM10 expression through direct interaction with RBM10 splice variants.
• RBM10 expression in RBM5-null tumors may contribute to tumor growth and metastasis.

Conclusions:

• RBM10 acts as an oncoprotein in RBM5-deficient SCLC, opposing its hypothesized tumor-suppressor role.
• The interaction between RBM5 and RBM10 influences SCLC progression.
• Measuring RBM10 and RBM5 expression in clinical samples may offer prognostic and predictive value for SCLC patients.